{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T16:59:52Z","timestamp":1770137992682,"version":"3.49.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.02527","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T04:39:29Z","timestamp":1571978369000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Serum Clusterin and Complement Factor H May Be Biomarkers Differentiate Primary Sj\u00f6gren's Syndrome With and Without Neuromyelitis Optica Spectrum Disorder"],"prefix":"10.3389","volume":"10","author":[{"given":"Lin","family":"Qiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuiwen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunyun","family":"Fei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,10,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.semarthrit.2010.05.005","article-title":"Neuromyelitis optica spectrum disorder as an initial presentation of primary Sjogren's syndrome","volume":"40","author":"Kahlenberg","year":"2011","journal-title":"Semin Arthritis Rheum."},{"key":"B3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s10072-016-2751-2","article-title":"Comparisons of presentations and outcomes of neuromyelitis optica patients with and without Sjogren's syndrome","volume":"38","author":"Zhong","year":"2017","journal-title":"Neurol Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1212\/01.wnl.0000049912.02954.2c","article-title":"Neuromyelitis optica: clinical predictors of a relapsing course and survival","volume":"60","author":"Wingerchuk","year":"2003","journal-title":"Neurology."},{"key":"B5","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/01.md.0000141099.53742.16","article-title":"Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients","volume":"83","author":"Delalande","year":"2004","journal-title":"Medicine."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/j.revmed.2009.08.018","article-title":"[Primary Sjogren's syndrome and neuromyelitis optica]","volume":"31","author":"Chourkani","year":"2010","journal-title":"Rev Med Interne."},{"key":"B7","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1468-1331.2011.03479.x","article-title":"Anti-aquaporin-4 antibodies in the context of assorted immune-mediated diseases","volume":"19","author":"Dellavance","year":"2012","journal-title":"Eur J Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1002\/acr.23107","article-title":"Relationship between neuromyelitis optica spectrum disorder and Sjogren's syndrome: central nervous system extraglandular disease or unrelated, co-occurring autoimmunity?","volume":"69","author":"Birnbaum","year":"2017","journal-title":"Arthritis Care Res."},{"key":"B9","first-page":"1067","article-title":"Primary Sjogren's syndrome with central nervous system involvement","volume":"30","author":"Alhomoud","year":"2009","journal-title":"Saudi Med J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1177\/1352458509106228","article-title":"Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica","volume":"15","author":"Min","year":"2009","journal-title":"Mult Scler."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e1145","DOI":"10.1097\/MD.0000000000001145","article-title":"The clinical characteristics of primary Sjogren's syndrome with neuromyelitis optica spectrum disorder in China: a STROBE-compliant article","volume":"94","author":"Qiao","year":"2015","journal-title":"Medicine."},{"key":"B12","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1074\/mcp.M111.015529","article-title":"Identification of new autoantigens for primary biliary cirrhosis using human proteome microarrays","volume":"11","author":"Hu","year":"2012","journal-title":"Mol Cell Proteomics."},{"key":"B13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10238-013-0265-2","article-title":"Establishing serological classification tree model in rheumatoid arthritis using combination of MALDI-TOF-MS and magnetic beads","volume":"15","author":"Yan","year":"2015","journal-title":"Clin Exp Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1365-3083.2011.02590.x","article-title":"Exploring serological classification tree model of active pulmonary tuberculosis by magnetic beads pretreatment and MALDI-TOF MS analysis","volume":"74","author":"Deng","year":"2011","journal-title":"Scand J Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1080\/14789450.2017.1333904","article-title":"Updates on Sjogren's syndrome: from proteomics to protein biomarkers","volume":"14","author":"Baldini","year":"2017","journal-title":"Expert Rev Proteomics."},{"key":"B16","doi-asserted-by":"publisher","first-page":"8489","DOI":"10.3748\/wjg.v23.i48.8489","article-title":"Exploring pathogenesis of primary biliary cholangitis by proteomics: a pilot study","volume":"23","author":"Deng","year":"2017","journal-title":"World J Gastroenterol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1002\/elps.201400342","article-title":"Serological comparative proteomics analysis of mitochondrial autoantibody-negative and -positive primary biliary cirrhosis","volume":"36","author":"Deng","year":"2015","journal-title":"Electrophoresis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology."},{"key":"B20","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1021\/pr800570s","article-title":"2D-DIGE as a strategy to identify serum markers for the progression of prostate cancer","volume":"8","author":"Byrne","year":"2009","journal-title":"J Proteome Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1172\/JCI113531","article-title":"SP-40,40, a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis","volume":"81","author":"Murphy","year":"1988","journal-title":"J Clin Invest."},{"key":"B22","first-page":"615","article-title":"Complement regulatory proteins in the salivary glands and saliva of Sjogren's syndrome patients and healthy subjects","volume":"15","author":"Cuida","year":"1997","journal-title":"Clin Exp Rheumatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1002\/art.39015","article-title":"High fidelity between saliva proteomics and the biologic state of salivary glands defines biomarker signatures for primary Sjogren's syndrome","volume":"67","author":"Delaleu","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"5772","DOI":"10.1038\/srep05772","article-title":"Tear proteomic analysis of Sjogren syndrome patients with dry eye syndrome by two-dimensional-nano-liquid chromatography coupled with tandem mass spectrometry","volume":"4","author":"Li","year":"2014","journal-title":"Sci Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"5730","DOI":"10.4049\/jimmunol.181.8.5730","article-title":"Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment","volume":"181","author":"Vincent","year":"2008","journal-title":"J Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.4049\/jimmunol.1600135","article-title":"CFHR1-modified neural stem cells ameliorated brain injury in a mouse model of neuromyelitis optica spectrum disorders","volume":"197","author":"Shi","year":"2016","journal-title":"J Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/2051-5960-1-85","article-title":"T cell-activation in neuromyelitis optica lesions plays a role in their formation","volume":"1","author":"Pohl","year":"2013","journal-title":"Acta Neuropathol Commun."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02527\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T04:39:31Z","timestamp":1571978371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02527\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,25]]},"references-count":27,"alternative-id":["10.3389\/fimmu.2019.02527"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.02527","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,25]]},"article-number":"2527"}}